Neurological Disease Diagnostics Case Study (Huntington's & Alzheimer's Disease): Quantifying the Impact of Improved Biomarkers on Drug Sales
Marketline
Acceso al recurso
Entrá al contenido desde la opción principal o elegí otra fuente disponible.
Acceso institucional disponible
Cómo citar
Elegí el formato que necesitás y copiá la referencia al portapapeles.
APA 7
Marketline (s. f.). Neurological Disease Diagnostics Case Study (Huntington's & Alzheimer's Disease): Quantifying the Impact of Improved Biomarkers on Drug Sales. Marketline. https://search.ebscohost.com/direct.asp?db=bth&jid=8P21&scope=site
MLA
Marketline. Neurological Disease Diagnostics Case Study (Huntington's & Alzheimer's Disease): Quantifying the Impact of Improved Biomarkers on Drug Sales. Marketline. https://search.ebscohost.com/direct.asp?db=bth&jid=8P21&scope=site.
Chicago
Marketline. s. f. Neurological Disease Diagnostics Case Study (Huntington's & Alzheimer's Disease): Quantifying the Impact of Improved Biomarkers on Drug Sales. Marketline. https://search.ebscohost.com/direct.asp?db=bth&jid=8P21&scope=site.
Harvard
Marketline s. f, Neurological Disease Diagnostics Case Study (Huntington's & Alzheimer's Disease): Quantifying the Impact of Improved Biomarkers on Drug Sales, Marketline, available at: https://search.ebscohost.com/direct.asp?db=bth&jid=8P21&scope=site [Accessed 8 Aug. 2026].
Detalles del recurso
Información bibliográfica útil para confirmar que se trata del material correcto.
- Título
- Neurological Disease Diagnostics Case Study (Huntington's & Alzheimer's Disease): Quantifying the Impact of Improved Biomarkers on Drug Sales
- Autor / colaboradores
- Marketline
- Editorial
- Marketline